Home / Brands / Llorens Pharmaceutical

Llorens Pharmaceutical Recalls

1 recall on record · November 22, 2017 to November 22, 2017 · Drugs

November 22, 2017DrugsFDA

Llorens Pharmaceutical Corp. recalls Urin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene Blue 10.8 mg, Hyo

Hazard: Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.

Llorens Pharmaceutical Recalls | RecallWatchUSA